Smallpox Vaccination - Clarification | The Medical Letter Inc.

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1148

January 20, 2003

View Complete Issue Table of Contents 2019

Smallpox Vaccination - Clarification

Show Related Terms Hide Related Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2003 Jan 20;45(1148):8

Disclosures

Objective(s)

Select a term to see related articles Biological weapons Bioterrorism Biowarfare Cidofovir Copegus Dryvax Rebetol ribavirin Smallpox Smallpox vaccine vaccines Vaccinia Immune Globulin VIG Virazole Vistide

SUMMARY: The single sentence on vaccination site care in our recent article on Smallpox Vaccination (Vol. 45, page 2) needs clarification. In the past, the vaccination site was generally left uncovered, but current plans for Phase I call for it to be covered with both gauze to absorb liquid and a semipermeable membrane such as an Opsite dressing to prevent spread of the virus. This correction has been made in the web version of the issue.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.